Get the Stockscreener App
57.63
0.35%
0.20
Tarsus Pharmaceuticals Inc stock is traded at $57.63, with a volume of 683.41K.
It is up +0.35% in the last 24 hours and up +40.05% over the past month.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
See More
Previous Close:
$57.43
Open:
$57.43
24h Volume:
683.41K
Relative Volume:
1.10
Market Cap:
$2.43B
Revenue:
$17.39M
Net Income/Loss:
$-135.89M
P/E Ratio:
-12.42
EPS:
-4.64
Net Cash Flow:
$-123.00M
1W Performance:
-1.62%
1M Performance:
+40.05%
6M Performance:
+29.39%
1Y Performance:
+111.02%
1-Day Range:
$56.37
$58.08
1-Week Range:
$56.37
$59.76
52-Week Range:
$28.07
$59.76
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Name
Tarsus Pharmaceuticals Inc
Sector
Industry
Phone
(949) 409-9820
Address
15440 LAGUNA CANYON ROAD, IRVINE
Compare TARS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
57.63 | 2.42B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-27-25 | Resumed | H.C. Wainwright | Buy |
| Nov-20-23 | Initiated | Goldman | Neutral |
| Jul-18-23 | Initiated | William Blair | Outperform |
| May-18-23 | Initiated | Guggenheim | Buy |
| Aug-01-22 | Initiated | Barclays | Overweight |
| Dec-21-21 | Initiated | H.C. Wainwright | Buy |
| Nov-23-21 | Initiated | Oppenheimer | Outperform |
| Nov-10-20 | Initiated | BofA Securities | Buy |
| Nov-10-20 | Initiated | Jefferies | Buy |
| Nov-10-20 | Initiated | Ladenburg Thalmann | Buy |
| Nov-10-20 | Initiated | Raymond James | Strong Buy |
View All
Tarsus Pharmaceuticals Inc Stock (TARS) Latest News
Momentum divergence signals in Tarsus Pharmaceuticals Inc. chartQuarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Custom watchlist performance reports with Tarsus Pharmaceuticals Inc.2025 Volatility Report & Verified Entry Point Signals - Newser
Tarsus Pharmaceuticals Inc. stock prediction for this weekCPI Data & Weekly Return Optimization Plans - Newser
Should you wait for a breakout in Tarsus Pharmaceuticals Inc.Quarterly Market Summary & Precise Trade Entry Recommendations - Newser
Real time breakdown of Tarsus Pharmaceuticals Inc. stock performance - Newser
Is Tarsus Pharmaceuticals Inc. stock suitable for long term investingJuly 2025 Trade Ideas & Growth Focused Stock Pick Reports - خودرو بانک
What does recent volatility data suggest for Tarsus Pharmaceuticals Inc.Jobs Report & AI Driven Stock Reports - Newser
Candlestick signals on Tarsus Pharmaceuticals Inc. stock todayMarket Volume Summary & Real-Time Volume Surge Alerts - Newser
Smart tools for monitoring Tarsus Pharmaceuticals Inc.’s price actionDip Buying & Free Reliable Trade Execution Plans - Newser
Combining price and volume data for Tarsus Pharmaceuticals Inc.Quarterly Earnings Report & Consistent Profit Focused Trading Strategies - Newser
Will Tarsus Pharmaceuticals Inc. stock recover after earningsJuly 2025 Update & Stepwise Trade Signal Implementation - خودرو بانک
Is Tarsus Pharmaceuticals Inc. a cyclical or defensive stock2025 Trading Recap & Reliable Price Breakout Signals - خودرو بانک
Volatility clustering patterns for Tarsus Pharmaceuticals Inc.Portfolio Value Summary & Weekly Consistent Profit Watchlists - Newser
Tarsus Pharmaceuticals Inc. stock momentum explainedStop Loss & Daily Chart Pattern Signal Reports - Newser
Why Tarsus Pharmaceuticals Inc. is moving todayStock Surge & Reliable Momentum Entry Alerts - Newser
Technical Models Detect Momentum Build in Tarsus Pharmaceuticals Inc.2025 Technical Patterns & Weekly Setup with High ROI Potential - beatles.ru
Relative strength of Tarsus Pharmaceuticals Inc. in sector analysisJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - Newser
What data driven models say about Tarsus Pharmaceuticals Inc.’s futureJuly 2025 Patterns & Fast Entry and Exit Trade Plans - Newser
Applying Elliott Wave Theory to Tarsus Pharmaceuticals Inc.July 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Will Tarsus Pharmaceuticals Inc. bounce back from current support2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
Detecting support and resistance levels for Tarsus Pharmaceuticals Inc.July 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Does Tarsus Pharmaceuticals Inc. have a sustainable dividendJuly 2025 Update & Growth Oriented Trading Recommendations - خودرو بانک
Using Ichimoku Cloud for Tarsus Pharmaceuticals Inc. technicals2025 Investor Takeaways & Weekly High Momentum Picks - Newser
Using portfolio simulators with Tarsus Pharmaceuticals Inc. includedSwing Trade & Technical Pattern Based Buy Signals - Newser
How liquid is Tarsus Pharmaceuticals Inc. stockLayoff News & Community Verified Trade Signals - خودرو بانک
Can Tarsus Pharmaceuticals Inc. hit a new high this monthGap Down & Weekly Watchlist for Hot Stocks - Newser
What technical models suggest about Tarsus Pharmaceuticals Inc.’s comeback - Newser
Published on: 2025-09-03 00:33:31 - Newser
Can momentum traders help lift Tarsus Pharmaceuticals Inc.Weekly Investment Summary & Real-Time Buy Zone Alerts - Newser
Is Tarsus Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
Tarsus Pharmaceuticals stock hits 52-week high at 58.99 USD By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals stock hits 52-week high at 58.99 USD - Investing.com
Chart based exit strategy for Tarsus Pharmaceuticals Inc.Weekly Gains Report & Capital Efficient Trade Techniques - Newser
Is Tarsus Pharmaceuticals Inc. stock forming a triangle patternJuly 2025 Weekly Recap & Stepwise Trade Execution Plans - خودرو بانک
Will a bounce in Tarsus Pharmaceuticals Inc. offer an exitMarket Growth Review & Consistent Profit Trading Strategies - Newser
Is Tarsus Pharmaceuticals Inc. backed by strong institutional buying2025 Valuation Update & Weekly Sector Rotation Insights - خودرو بانک
Intraday Charts Show Spike in Tarsus Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - kangso.co.kr
Analyzing drawdowns of Tarsus Pharmaceuticals Inc. with statistical toolsMarket Performance Summary & Weekly High Potential Alerts - Newser
Tarsus Pharmaceuticals Inc Stock (TARS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):